{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T02:45:20Z","timestamp":1761101120459},"reference-count":49,"publisher":"Oxford University Press (OUP)","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,6,1]]},"DOI":"10.2146\/ajhp120246","type":"journal-article","created":{"date-parts":[[2013,5,17]],"date-time":"2013-05-17T21:54:24Z","timestamp":1368827664000},"page":"980-987","source":"Crossref","is-referenced-by-count":4,"title":["Development and implementation of a nurse-driven, sliding-scale nomogram for bivalirudin in the management of heparin-induced thrombocytopenia"],"prefix":"10.1093","volume":"70","author":[{"given":"Pamela K.","family":"Burcham","sequence":"first","affiliation":[{"name":"The Ohio State University Wexner Medical Center, Columbus"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erik E.","family":"Abel","sequence":"additional","affiliation":[{"name":"The Ohio State University Wexner Medical Center, Columbus"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anthony T.","family":"Gerlach","sequence":"additional","affiliation":[{"name":"The Ohio State University Wexner Medical Center, Columbus"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claire V.","family":"Murphy","sequence":"additional","affiliation":[{"name":"The Ohio State University Wexner Medical Center, Columbus"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcia","family":"Belcher","sequence":"additional","affiliation":[{"name":"The Ohio State University Wexner Medical Center, Columbus"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Danielle M.","family":"Blais","sequence":"additional","affiliation":[{"name":"The Ohio State University Wexner Medical Center, Columbus"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","reference":[{"key":"2019041607512424500_b1-0700980","first-page":"851","article-title":"Coagulopathy and platelet disorders in critically ill patients","volume":"76","author":"Levi","year":"2010","journal-title":"Minerva Anestesiol."},{"key":"2019041607512424500_b2-0700980","doi-asserted-by":"crossref","first-page":"2898","DOI":"10.1097\/01.CCM.0000248723.18068.90","article-title":"Heparin-induced thrombocytopenia in the critical care setting: diagnosis and management","volume":"34","author":"Napolitano","year":"2006","journal-title":"Crit Care Med."},{"key":"2019041607512424500_b3-0700980","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1016\/j.athoracsur.2003.09.034","article-title":"Heparin-induced thrombocytopenia and cardiac surgery","volume":"76","author":"Warkentin","year":"2003","journal-title":"Ann Thorac Surg."},{"key":"2019041607512424500_b4-0700980","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/S0002-9343(96)00258-6","article-title":"A 14-year study of heparin-induced thrombocytopenia","volume":"101","author":"Warkentin","year":"1996","journal-title":"Am J Med."},{"key":"2019041607512424500_b5-0700980","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1056\/NEJMcp052967","article-title":"Clinical practice. Heparin-induced thrombocytopenia","volume":"355","author":"Arepally","year":"2006","journal-title":"N Engl J Med."},{"key":"2019041607512424500_b6-0700980","volume-title":"Refludan (lepirudin) package insert","year":"2006"},{"key":"2019041607512424500_b7-0700980","volume-title":"Argatroban package insert","year":"2009"},{"key":"2019041607512424500_b8-0700980","unstructured":"Food and Drug Administration. Drug safety and availability: drugs to be discontinued. www.fda.gov\/Drugs\/DrugSafety\/DrugShortage\/ucm050794.htm (accessed 2013 Mar 19)."},{"key":"2019041607512424500_b9-0700980","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1161\/01.CIR.100.6.587","article-title":"Lepirudin (recombinant hirudin) for parenteral anticoagulation in patients with heparin-induced thrombocytopenia","volume":"100","author":"Greinacher","year":"1999","journal-title":"Circulation."},{"key":"2019041607512424500_b10-0700980","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1161\/01.CIR.99.1.73","article-title":"Recombinant hirudin (lepirudin) provides safe and effective anticoagulation in patients with heparin-induced thrombocytopenia: a prospective study","volume":"99","author":"Greinacher","year":"1999","journal-title":"Circulation."},{"key":"2019041607512424500_b11-0700980","doi-asserted-by":"crossref","first-page":"2428","DOI":"10.1111\/j.1538-7836.2005.01623.x","article-title":"Lepirudin in patients with heparin-induced thrombocytopenia\u2014results of the third prospective study (HAT-3) and a combined analysis of HAT-1, HAT-2, and HAT-3","volume":"3","author":"Lubenow","year":"2005","journal-title":"J Thromb Haemost."},{"key":"2019041607512424500_b12-0700980","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1182\/blood-2006-02-001057","article-title":"Predictive factors for thrombosis and major bleeding in an observational study in 181 patients with heparin-induced thrombocytopenia treated with lepirudin","volume":"108","author":"Tardy","year":"2006","journal-title":"Blood."},{"key":"2019041607512424500_b13-0700980","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1111\/j.1365-2141.2009.07764.x","article-title":"Extremely low doses of lepirudin in a patient with heparin-induced thrombocytopenia, high bleeding risk and renal insufficiency","volume":"146","author":"Tardy-Poncet","year":"2009","journal-title":"Br J Haematol."},{"key":"2019041607512424500_b14-0700980","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.2146\/ajhp110540","article-title":"Direct thrombin inhibitors for management of heparin-induced thrombocytopenia in patients receiving renal replacement therapy: comparison of clinical outcomes","volume":"69","author":"Abel","year":"2012","journal-title":"Am J Health-Syst Pharm."},{"key":"2019041607512424500_b15-0700980","doi-asserted-by":"crossref","first-page":"c80","DOI":"10.1159\/000139993","article-title":"Argatroban anticoagulation in renal dysfunction: a literature analysis","volume":"109","author":"Hursting","year":"2008","journal-title":"Nephron Clin Pract."},{"key":"2019041607512424500_b16-0700980","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1345\/aph.1L224","article-title":"Effects of critical illness and organ failure on therapeutic argatroban dosage requirements in patients with suspected or confirmed heparin-induced thrombocytopenia","volume":"43","author":"Keegan","year":"2009","journal-title":"Ann Pharmacother."},{"key":"2019041607512424500_b17-0700980","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1016\/j.jtcvs.2007.01.008","article-title":"Argatroban anticoagulation for renal replacement therapy in patients with heparin-induced thrombocytopenia after cardiovascular surgery","volume":"133","author":"Koster","year":"2007","journal-title":"J Thorac Cardiovasc Surg."},{"key":"2019041607512424500_b18-0700980","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1345\/aph.1G033","article-title":"Argatroban anticoagulation in patients with heparin-induced thrombocytopenia requiring renal replacement therapy","volume":"39","author":"Reddy","year":"2005","journal-title":"Ann Pharmacother."},{"key":"2019041607512424500_b19-0700980","doi-asserted-by":"crossref","first-page":"R90","DOI":"10.1186\/cc9024","article-title":"Argatroban therapy for heparin-induced thrombocytopenia in ICU patients with multiple organ dysfunction syndrome: a retrospective study","volume":"14","author":"Saugel","year":"2010","journal-title":"Crit Care."},{"key":"2019041607512424500_b20-0700980","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1592\/phco.29.9.1073","article-title":"Argatroban dosage requirements and outcomes in intensive care versus non-intensive care patients","volume":"29","author":"Smythe","year":"2009","journal-title":"Pharmacotherapy."},{"key":"2019041607512424500_b21-0700980","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1345\/aph.1E480","article-title":"Argatroban and renal replacement therapy in patients with heparin-induced thrombocytopenia","volume":"39","author":"Tang","year":"2005","journal-title":"Ann Pharmacother."},{"issue":"suppl F","key":"2019041607512424500_b22-0700980","first-page":"33F","article-title":"The use of bivalirudin in patients with renal impairment","volume":"12","author":"Robson","year":"2000","journal-title":"J Invasive Cardiol."},{"key":"2019041607512424500_b23-0700980","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1067\/mcp.2002.124522","article-title":"Bivalirudin pharmacokinetics and pharmacodynamics: effect of renal function, dose, and gender","volume":"71","author":"Robson","year":"2002","journal-title":"Clin Pharmacol Ther."},{"key":"2019041607512424500_b24-0700980","volume-title":"Angiomax (bivalirudin) package insert","year":"2005"},{"key":"2019041607512424500_b25-0700980","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1592\/phco.28.9.1115","article-title":"Safety, efficacy, and dosing requirements of bivalirudin in patients with heparin-induced thrombocytopenia","volume":"28","author":"Kiser","year":"2008","journal-title":"Pharmacotherapy."},{"key":"2019041607512424500_b26-0700980","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/s11239-011-0677-3","article-title":"Evaluation of dose requirements for prolonged bivalirudin administration in patients with renal insufficiency and suspected heparin-induced thrombocytopenia","volume":"33","author":"Wisler","year":"2012","journal-title":"J Thromb Thrombolysis."},{"key":"2019041607512424500_b27-0700980","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1592\/phco.31.9.850","article-title":"Correlation of bivalirudin dose with creatinine clearance during treatment of heparin-induced thrombocytopenia","volume":"31","author":"Runyan","year":"2011","journal-title":"Pharmacotherapy."},{"key":"2019041607512424500_b28-0700980","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1345\/aph.1Q177","article-title":"Bivalirudin dosing adjustments for reduced renal function with or without hemodialysis in the management of heparin-induced thrombocytopenia","volume":"45","author":"Tsu","year":"2011","journal-title":"Ann Pharmacother."},{"key":"2019041607512424500_b29-0700980","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1053\/j.jvca.2010.12.015","article-title":"Update in hematology: heparin-induced thrombocytopenia and bivalirudin","volume":"25","author":"Augoustides","year":"2011","journal-title":"J Cardiothorac Vasc Anesth."},{"key":"2019041607512424500_b30-0700980","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1592\/phco.30.12.1229","article-title":"Comparison of bivalirudin and argatroban for the management of heparin-induced thrombocytopenia","volume":"30","author":"Skrupky","year":"2010","journal-title":"Pharmacotherapy."},{"key":"2019041607512424500_b31-0700980","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1592\/phco.26.4.452","article-title":"Evaluation of bivalirudin treatment for heparin-induced thrombocytopenia in critically ill patients with hepatic and\/or renal dysfunction","volume":"26","author":"Kiser","year":"2006","journal-title":"Pharmacotherapy."},{"key":"2019041607512424500_b32-0700980","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1592\/phco.26.2.229","article-title":"Treatment of heparin-induced thrombocytopenia: is there a role for bivalirudin?","volume":"26","author":"Seybert","year":"2006","journal-title":"Pharmacotherapy."},{"key":"2019041607512424500_b33-0700980","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1345\/aph.1L213","article-title":"Weight-based argatroban dosing nomogram for treatment of heparin-induced thrombocytopenia","volume":"43","author":"Ansara","year":"2009","journal-title":"Ann Pharmacother."},{"key":"2019041607512424500_b34-0700980","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1592\/phco.21.15.1167.33895","article-title":"An institution-specific heparin titration nomogram: development, validation, and assessment of compliance","volume":"21","author":"Sherman","year":"2001","journal-title":"Pharmacotherapy."},{"key":"2019041607512424500_b35-0700980","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1001\/archinte.1996.00440140067006","article-title":"The effectiveness of implementing the weight-based heparin nomogram as a practice guideline","volume":"156","author":"Raschke","year":"1996","journal-title":"Arch Intern Med."},{"key":"2019041607512424500_b36-0700980","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1177\/1358863X9600100202","article-title":"Heparin administration via nomogram versus a standard approach in venous and arterial thromboembolic disease","volume":"1","author":"Jaff","year":"1996","journal-title":"Vasc Med."},{"key":"2019041607512424500_b37-0700980","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1001\/archinte.1995.00430050104011","article-title":"Appropriate use of heparin. Empiric vs nomogram-based dosing","volume":"155","author":"Gunnarsson","year":"1995","journal-title":"Arch Intern Med."},{"key":"2019041607512424500_b38-0700980","doi-asserted-by":"crossref","first-page":"874","DOI":"10.7326\/0003-4819-119-9-199311010-00002","article-title":"The weight-based heparin dosing nomogram compared with a \u201cstandard care\u201d nomogram. A randomized controlled trial","volume":"119","author":"Raschke","year":"1993","journal-title":"Ann Intern Med."},{"key":"2019041607512424500_b39-0700980","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1345\/aph.1D163","article-title":"Effect of renal function on the pharmacodynamics of argatroban","volume":"38","author":"Arpino","year":"2004","journal-title":"Ann Pharmacother."},{"key":"2019041607512424500_b40-0700980","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1002\/ajh.21955","article-title":"Evaluation of empiric versus nomogram-based direct thrombin inhibitor management in patients with suspected heparin-induced thrombocytopenia","volume":"86","author":"Kiser","year":"2011","journal-title":"Am J Hematol."},{"key":"2019041607512424500_b41-0700980","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1186\/1472-6963-11-175","article-title":"Medication knowledge, certainty, and risk of errors in health care: a cross-sectional study","volume":"11","author":"Simonsen","year":"2011","journal-title":"BMC Health Serv Res."},{"key":"2019041607512424500_b42-0700980","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1111\/j.1538-7836.2006.01787.x","article-title":"Evaluation of pretest clinical score (4 T\u2019s) for the diagnosis of heparin-induced thrombocytopenia in two clinical settings","volume":"4","author":"Lo","year":"2006","journal-title":"J Thromb Haemost."},{"issue":"suppl 2","key":"2019041607512424500_b43-0700980","doi-asserted-by":"crossref","first-page":"e495S","DOI":"10.1378\/chest.11-2303","article-title":"Treatment and prevention of heparin-induced thrombocytopenia: antithrombotic therapy and prevention of thrombosis, 9th ed. American College of Chest Physicians evidence-based clinical practice guidelines","volume":"141","author":"Linkins","year":"2012","journal-title":"Chest."},{"issue":"suppl 6","key":"2019041607512424500_b44-0700980","doi-asserted-by":"crossref","first-page":"340S","DOI":"10.1378\/chest.08-0677","article-title":"Treatment and prevention of heparin-induced thrombocytopenia: American College of Chest Physicians evidence-based clinical practice guidelines (8th edition)","volume":"133","author":"Warkentin","year":"2008","journal-title":"Chest."},{"key":"2019041607512424500_b45-0700980","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1001\/jama.289.7.853","article-title":"Bivalirudin and provisional glycoprotein IIb\/IIIa blockade compared with heparin and planned glycoprotein IIb\/IIIa blockade during percutaneous coronary intervention: REPLACE-2 randomized trial","volume":"289","author":"Lincoff","year":"2003","journal-title":"JAMA."},{"key":"2019041607512424500_b46-0700980","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1592\/phco.26.4.461","article-title":"Evaluation of treatment with direct thrombin inhibitors in patients with heparin-induced thrombocytopenia","volume":"26","author":"Dang","year":"2006","journal-title":"Pharmacotherapy."},{"key":"2019041607512424500_b47-0700980","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1056\/NEJMct1103720","article-title":"Extracorporeal membrane oxygenation for ARDS in adults","volume":"365","author":"Brodie","year":"2011","journal-title":"N Engl J Med."},{"key":"2019041607512424500_b48-0700980","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1177\/1089253209347384","article-title":"Anticoagulation and coagulation management for ECMO","volume":"13","author":"Oliver","year":"2009","journal-title":"Semin Cardiothorac Vasc Anesth."},{"issue":"suppl 4","key":"2019041607512424500_b49-0700980","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.healun.2010.01.011","article-title":"Clinical management of continuous-flow left ventricular assist devices in advanced heart failure","volume":"29","author":"Slaughter","year":"2010","journal-title":"J Heart Lung Transplant."}],"container-title":["American Journal of Health-System Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ajhp\/article-pdf\/70\/11\/980\/28456426\/ajhp0980.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,16]],"date-time":"2019-04-16T11:57:20Z","timestamp":1555415840000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ajhp\/article\/70\/11\/980\/5112824"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,6,1]]},"references-count":49,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2013,6,1]]}},"URL":"https:\/\/doi.org\/10.2146\/ajhp120246","relation":{},"ISSN":["1079-2082","1535-2900"],"issn-type":[{"value":"1079-2082","type":"print"},{"value":"1535-2900","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2013,6,1]]},"published":{"date-parts":[[2013,6,1]]}}}